At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Statistical Basis for Hemochromatosis Screening
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Feb 18, 2016
In Brief
An observational study for Blood Disease and Hemochromatosis. Completed.
Detailed Summary
To determine optimal values for transferrin saturation for use in population screening for hereditary hemochromatosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBlood Disease, Hemochromatosis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 1997
First PostedMay 2000
Study CompletionJun 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartJul 1, 1997
Study CompletionJun 1, 2000
TodayJul 2, 2026
Posted 26.1 years ago